General Anesthesia Drug Dosing Protocol for Standard Adult Patient
For a typical adult patient (70 kg, ASA I-II, no organ dysfunction) undergoing general anesthesia, use propofol 1.5-2.5 mg/kg IV for induction, fentanyl 1-2 mcg/kg IV for analgesia, and rocuronium 0.6 mg/kg IV for neuromuscular blockade, followed by maintenance with either propofol infusion or volatile anesthetic with supplemental opioids titrated to surgical stimulus. 1
Pre-Induction Phase
Antisialogogue (Optional, 30-60 minutes pre-procedure)
- Glycopyrronium bromide 0.2-0.4 mg IM or 0.1-0.2 mg IV if administered immediately before induction 2
- Note: May produce significant tachycardia; less commonly, atropine 0.3-0.6 mg IM or 0.2-0.3 mg IV can be used but causes more tachycardia 2
Anxiolysis/Amnesia (Optional)
- Midazolam 0.02 mg/kg IV or 1-2 mg IV titrated to effect 1
- Peak effect occurs at 5-10 minutes, so exercise caution with multiple doses 2
- Reduce dose by at least 20% in elderly patients (>60 years) or ASA III-IV 1
Induction Phase
Step 1: Pre-oxygenation
- Administer 100% oxygen for 3-5 minutes via face mask 2
Step 2: Opioid Administration
- Fentanyl 1-2 mcg/kg IV (for 70 kg patient: 70-140 mcg) 1
- Alternative: Remifentanil 0.5-1 mcg/kg/min infusion with initial 1 mcg/kg bolus over 30-60 seconds if intubation planned within 8 minutes 3
Step 3: Hypnotic Induction Agent
- Propofol 1.5-2.5 mg/kg IV (for 70 kg patient: 105-175 mg) 1
- Alternative for hemodynamically unstable patients: Etomidate 10-20 mg IV 1
- Alternative with analgesic properties: Ketamine 1-2 mg/kg IV 1
Step 4: Neuromuscular Blockade (if intubation required)
- Rocuronium 0.6 mg/kg IV (for 70 kg patient: 42 mg) for standard intubation 2
- Succinylcholine 1 mg/kg IV (for 70 kg patient: 70 mg) for rapid sequence induction only 2
- Caution: Succinylcholine is a malignant hyperthermia trigger agent 2
- Wait 60-90 seconds for rocuronium or 45-60 seconds for succinylcholine before laryngoscopy 2
Step 5: Laryngoscopy and Intubation
- Perform laryngoscopy and endotracheal intubation 2
- Confirm tube placement with two-point check: (1) visualization of tube through vocal cords, and (2) capnography to exclude esophageal intubation 2
Maintenance Phase
Option A: Total Intravenous Anesthesia (TIVA)
- Propofol infusion: 100-200 mcg/kg/min (for 70 kg patient: 7-14 mg/min or 420-840 mg/hr) 1
- Remifentanil infusion: 0.05-2 mcg/kg/min depending on surgical stimulus 3
Option B: Volatile Anesthetic Maintenance
- Desflurane 2.6-8.4% with nitrous oxide 60% or 3.1-8.9% in oxygen alone 4
- Isoflurane 0.7-1.4% with nitrous oxide 60% 4
- Sevoflurane 0.3-1.5 MAC 1
- Supplemental fentanyl boluses 0.5-1 mcg/kg as needed every 30-60 minutes 2
- Caution: All volatile anesthetics are malignant hyperthermia trigger agents 2
Multimodal Analgesia (Opioid-Sparing Strategy)
- Acetaminophen 15-20 mg/kg IV loading dose (for 70 kg patient: 1050-1400 mg), then 10-15 mg/kg every 6-8 hours (maximum 60 mg/kg/day) 1
- Ketorolac 15-30 mg IV (if not contraindicated) 1
- Ketamine 0.5 mg/kg IV bolus followed by 0.25-0.5 mg/kg/hr infusion for additional analgesia 1
- Lidocaine 1.5 mg/kg IV bolus followed by 1.5 mg/kg/hr infusion 1
Adjunctive Sedation (if needed)
- Dexmedetomidine 0.5-1 mcg/kg IV loading dose over 5 minutes, followed by 0.2-0.7 mcg/kg/hr infusion 1
- Caution: Bolus dosing associated with hypertension and bradycardia 2
Antiemetic Prophylaxis
- Dexamethasone 0.15-0.25 mg/kg IV (for 70 kg patient: 10.5-17.5 mg, typically give 4-8 mg) at induction 1
- Ondansetron 4 mg IV near end of surgery 5
Emergence and Recovery Phase
Reversal of Neuromuscular Blockade
- Monitor Train-of-Four (TOF) ratio; must be >90% before extubation 2
- Neostigmine 0.04-0.07 mg/kg IV with glycopyrrolate 0.01 mg/kg IV if TOF <90% 2
- Alternative: Sugammadex 2-4 mg/kg IV for rapid rocuronium reversal 2
Discontinuation of Anesthetics
- Stop volatile anesthetics 5-10 minutes before anticipated end of surgery 4
- Reduce propofol infusion rate by 50% in final 10 minutes 1
- Continue remifentanil until end of procedure, then discontinue (rapid offset within 3-5 minutes) 3
Extubation Criteria
- TOF ratio >90% 2
- Regular spontaneous breathing with adequate gas exchange 2
- Satisfactory hemodynamic conditions 2
- Awake patient (eye opening/response to commands) 2
Critical Monitoring Requirements
- Continuous pulse oximetry, capnography, blood pressure, heart rate, and respiratory rate throughout entire anesthetic 1
- Capnography monitoring every 5-15 minutes until discharge criteria met 1
- Neuromuscular blockade monitoring when muscle relaxants used 2
Emergency Reversal Agents (Must Be Immediately Available)
- Naloxone for opioid reversal: 0.04-0.4 mg IV, repeat every 2-3 minutes as needed 1
- Flumazenil for benzodiazepine reversal: 0.2 mg IV over 15 seconds, then 0.1 mg every 60 seconds (maximum 1 mg) 1
- Dantrolene for malignant hyperthermia: 2 mg/kg IV initial dose, repeat until symptoms resolve (may need 36-50 ampoules for adult; maximum may exceed 10 mg/kg) 2
Common Pitfalls to Avoid
Respiratory Depression
- Avoid excessive opioid dosing, especially when combining with propofol or benzodiazepines 1
- Use capnography for early detection of hypoventilation 1
- With propofol TCI, avoid effect-site concentrations >1.5 mcg/ml when using concomitant opioids 2
Inadequate Analgesia
- Do not rely on single-agent analgesia; employ multimodal approach combining acetaminophen, NSAIDs, ketamine, and regional techniques 1
- Anticipate surgical stimulus and provide supplemental boluses before intense stimulation 3
Malignant Hyperthermia Risk
- Avoid volatile anesthetics and succinylcholine in susceptible patients 2
- If MH suspected: immediately stop trigger agents, hyperventilate with 100% oxygen, give dantrolene 2 mg/kg IV, and call for help 2
Hemodynamic Instability
- Reduce induction doses by 50% in elderly patients (>65 years) to prevent hypotension 1
- Consider etomidate or ketamine for hemodynamically unstable patients instead of propofol 1
- Ketamine 0.5 mg/kg may protect against post-induction hypotension better than fentanyl alone 6